Mental health (MH) hospitalizations at medical hospitals are associated with longer length of stay (LOS) compared with non-MH hospitalizations, but patient factors and costs associated with prolonged MH hospitalizations are unknown. The objective of this paper is to assess patient clinical and demographic factors associated with prolonged MH hospitalizations and describe variation in MH LOS across US children’s hospitals.
We studied children aged 5 to 20 years hospitalized with a primary MH diagnosis during 2021 and 2022 across 46 children’s hospitals using the Pediatric Health Information System database. Generalized estimating equations, clustered on hospital, tested associations between patient characteristics with prolonged MH hospitalization, defined as those in the 95th percentile or above (>14 days).
Among 42 654 primary MH hospitalizations, most were aged 14 to 18 (62.4%), female (68.5%), and non-Hispanic white (53.8%). The most common primary MH diagnoses were suicide/self-injury (37.4%), depressive disorders (16.6%), and eating disorders (10.9%). The median (interquartile range) LOS was 2 days (1–5), but 2169 (5.1%) experienced a hospitalization >14 days. In adjusted analyses, race and ethnicity, category of MH diagnosis, and increasing medical and MH complexity were associated with prolonged hospitalization.
Our results emphasize several diagnoses and clinical descriptors for targeted interventions, such as behavioral and inpatient MH resources and discharge planning. Expanded investment in both community and inpatient MH supports have the potential to improve health equity and reduce prolonged MH hospitalizations.
The proportion of children hospitalized for mental health (MH) conditions at medical hospitals has increased over the past decade, reflecting the growing national MH emergency and insufficient outpatient and inpatient MH resources.1 Acute care admissions for a primary MH reason now account for 20% of all pediatric hospitalizations and 29% of pediatric hospital days.1 Within acute care settings, children primarily hospitalized for an MH condition have a longer length of stay (LOS) compared with children hospitalized for other reasons2 ; however, it is unknown which patients with MH hospitalizations have the longest LOS.
Exploring patient factors associated with prolonged MH hospitalizations is critical because children with MH hospitalizations are at higher risk for experiencing acute agitation, behavioral escalations, physical and pharmacological restraint, and involvement in events associated with physical and emotional harm to staff.3–7 Medical hospitals are rarely poised to optimally care for children with acute or complex behavioral needs, resulting in potentially ineffective care for patients and emotional distress among families and staff.8 Compounding this, MH hospitalizations are often associated with excessive or avoidable days (ie, days that patients would have been more appropriately treated in a different care setting).8 Hospital costs associated with MH hospitalizations are overall greater than non-MH hospitalizations,9 and certain MH conditions, such as depressive disorders, are associated with high hospital costs.10 However, the economic burden of MH hospitalizations has not been fully described, and the impact of prolonged MH hospitalizations on hospital costs is unknown.
Understanding characteristics associated with prolonged MH hospitalizations is critical to inform interventions that may improve patient and staff outcomes during a prolonged hospitalization and reduce unnecessary hospital days.
Our primary objective was to assess clinical and demographic factors associated with prolonged MH hospitalizations and explore hospital variation in the prevalence of prolonged MH hospitalizations. Our secondary outcome was to assess hospital costs associated with prolonged MH hospitalizations.
Methods
Study Design, Data Source, and Population
We performed a multicenter, retrospective cohort study of children aged 5 to 20 years hospitalized with a primary MH discharge diagnosis at 1 of 46 US children’s hospitals between January 1, 2021, and December 31, 2022. Data were obtained from the Pediatric Health Information System (PHIS), which is an administrative and billing database of children’s hospitals affiliated with the Children’s Hospital Association (Lenexa, Kansas). We included children up to 20 years of age to capture patients with medical complexity who may receive care at a children’s hospital past age 18, as well as patients who may have unique barriers to discharge (eg, guardianship concerns). To focus on MH hospitalizations at acute care facilities, we excluded patients billed for a designated psychiatric or rehabilitation bed. We also excluded patients transferred into the hospital to accurately capture the total duration of hospitalization. Figure 1 displays a consort diagram of our included study population.
Primary Exposure Variable
International Classification of Disease, 10th Edition, Clinical Modification, codes for MH diagnoses were classified using the Child and Adolescent MH Disorders (CAMHD) classification system, which aligns diagnosis codes with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, psychiatric diagnosis groups.11,12 To organize our large sample, we combined certain conditions and analyzed the following groups: Anxiety and obsessive compulsive disorders; autism spectrum disorder; bipolar disorders; communication disorders; depressive disorders; developmental, motor, and learning disorders; disruptive, impulse control, and conduct disorders; feeding and eating disorders; intellectual disability; schizophrenia and psychotic disorders; substance-abuse related illnesses; suicidality/self-injury; and trauma-related disorders. Supplemental Table 3 displays the collapsing of CAMHD categories into our diagnostic categories. This study exams all MH conditions classified using the CAMHD system, including feeding and eating disorders. Hospitalizations for feeding and eating disorders may differ in unique ways from other MH hospitalizations, including patient demographics, indication for admission, and discharge criteria, therefore we conducted a sensitivity analysis excluding hospitalizations for feeding and eating disorder. Patients with multiple diagnosis codes within 1 MH diagnostic category were characterized as having 1 MH diagnosis (ie, the total count of MH diagnoses was based on the presence of MH diagnosis codes in separate study diagnostic categories and not total MH diagnosis codes).
Outcome Measures
The primary outcome was prolonged LOS, defined as the 95th percentile of LOS for all children hospitalized with a primary MH diagnosis, which equated to LOS ≥14 days. Our secondary outcome was hospital cost. Costs were estimated from charges using annual hospital specific cost-to-charge ratios from the Centers for Medicare and Medicaid cost reports.
Covariates
Patient demographics and clinical characteristics
We included the following patient demographic characteristics: Age, sex, race and ethnicity, and payer. Race and ethnicity data were treated as a social construct, rather than a biologic category. Race and ethnicity data were collected by individual PHIS hospitals per their procedures and then submitted to PHIS. Race and ethnicity categories included non-Hispanic Black, non-Hispanic white, Hispanic, Asian, and other. Included in the other category include Pacific Islander, Native American, and other unspecified. Payer categories included government, private, and other. Clinical characteristics included the CAMHD category of primary MH condition, the number of MH conditions, and the number of complex chronic conditions. Complex chronic conditions were identified using Feudtner et al’s definition, and included medical conditions expected to last at least 1 year and to involve either several different organ systems or 1 organ system severely.13 Because of limitations with our data set, we did not include any descriptors for “medical clearance” versus ongoing medical needs.
Hospitalization characteristics
Hospitalization characteristics included any ICU use and discharge disposition. Discharge disposition was categorized as home, transfer to other medical hospital, transfer to inpatient psychiatric facility or residential facility, and other. Within other were the following discharge dispositions: Deceased, left against medical advice, unknown, and interhospital transfer.
Statistical Analysis
Frequencies with percentages or medians with interquartile ranges described characteristics of the study population and bivariate comparisons were made using χ2 or Wilcoxon rank tests. Multivariable models were constructed with generalized estimating equations, clustering on hospital, to estimate the adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for prolonged LOS. All demographic and clinical characteristic predictor variables were statistically significant in bivariate analyses and, therefore, were included in the model. Non-Hispanic white was selected as the reference for race and ethnicity variables, given that this was the largest group and this approach resulted in easily interpretable (>1.0) ORs. Anxiety disorders was selected as a referent for MH diagnoses, to allow for positive ORs among other groups and avoid referent variables that may overlap with other variables (ie, depression and suicidality/self-harm). To describe interhospital variation in prolonged LOS for children hospitalized with a primary MH diagnosis, we calculated the hospital-level adjusted percentage of all MH hospitalizations that were prolonged. All statistical analyses were performed using SAS v.9.4 (SAS Institute, Cary, North Carolina), and P < .05 was considered statistically significant. This study was deemed nonhuman subjects research by the Office of Research Integrity at Children’s Mercy Kansas City.
We hypothesized that patients with an eating disorder and their related goals for hospitalization may have been unique compared with patients with other MH diagnoses. Therefore, we conducted a sensitivity analysis excluding patients with a primary diagnosis of a feeding or eating disorder.
Results
Study Population
Among 42 654 MH hospitalizations at 46 Children’s Hospitals, 2169 (5.1%) had a prolonged LOS (Table 1). Females accounted for most MH hospitalizations (68.5%). Non-Hispanic white children accounted for 53.8% of hospitalizations, and almost half (48.4%) of those with MH hospitalizations had government insurance. Suicide/self-injury was the most common (37.4%) primary MH condition, followed by depressive disorders (16.6%) and eating disorders (10.9%). Most (60.6%) hospitalizations were associated with 3 or more MH diagnostic categories. Most hospitalizations (80%) had no associated complex chronic conditions, and most hospitalizations (64.5%) were discharged to home. The distribution of LOS followed a positively skewed distribution with an extreme right tail. Although prolonged hospitalizations only accounted for 5.1% of all MH hospitalizations, prolonged MH hospitalizations accounted for 33.3% of MH hospital days (62 628 days) and 26.2% of MH hospitalization costs ($132 428 435).
Characteristic . | Overall . | <14 D LOS . | 14 + D LOS . |
---|---|---|---|
N discharges | 42 654 | 40 485 (94.9) | 2169 (5.1) |
Age at admissiona | |||
5–10 y | 4375 (10.3) | 4194 (10.4) | 181 (8.3) |
11–13 y | 11 015 (25.8) | 10 462 (25.8) | 553 (25.5) |
14–18 y | 26 629 (62.4) | 25 253 (62.4) | 1376 (63.4) |
19–20 y | 635 (1.5) | 576 (1.4) | 59 (2.7) |
Sexa | |||
Male | 13 405 (31.5) | 12 768 (31.6) | 637 (29.4) |
Female | 29 218 (68.5) | 27 690 (68.4) | 1528 (70.6) |
Race/ethnicitya | |||
Non-Hispanic white | 22 950 (53.8) | 21 795 (53.8) | 1155 (53.3) |
Non-Hispanic Black | 8605 (20.2) | 8170 (20.2) | 435 (20.1) |
Hispanic | 7348 (17.2) | 7004 (17.3) | 344 (15.9) |
Asian | 895 (2.1) | 836 (2.1) | 59 (2.7) |
Otherb | 2856 (6.7) | 2680 (6.6) | 176 (8.1) |
Payera | |||
Government | 20 632 (48.4) | 19 645 (48.5) | 987 (45.5) |
Private | 19 077 (44.7) | 18 012 (44.5) | 1065 (49.1) |
Otherc | 2945 (6.9) | 2828 (7) | 117 (5.4) |
Primary MH conditiona | |||
ADHD | 566 (1.3) | 545 (1.3) | 21 (1) |
Accidental/undetermined poisoning | 979 (2.3) | 966 (2.4) | 13 (0.6) |
Anxiety disorders | 1420 (3.3) | 1405 (3.5) | 15 (0.7) |
Autism spectrum disorder | 1043 (2.4) | 955 (2.4) | 88 (4.1) |
Bipolar and related disorders | 390 (0.9) | 368 (0.9) | 22 (1) |
Depressive disorders | 7079 (16.6) | 6840 (16.9) | 239 (11) |
Developmental delay NOS | 318 (0.7) | 313 (0.8) | 5 (0.2) |
Disruptive, impulse control and conduct disorders | 1622 (3.8) | 1470 (3.6) | 152 (7) |
Feeding/eating disorders | 4660 (10.9) | 3637 (9) | 1023 (47.2) |
Otherd | 2708 (6.3) | 2628 (6.5) | 80 (3.7) |
Schizophrenia spectrum and other psychotic disorders | 972 (2.3) | 848 (2.1) | 124 (5.7) |
Somatic symptom and related disorders | 2134 (5) | 2097 (5.2) | 37 (1.7) |
Substance-related disorders | 1213 (2.8) | 1193 (2.9) | 20 (0.9) |
Suicide or self-injury | 15 936 (37.4) | 15 641 (38.6) | 295 (13.6) |
Trauma and stressor-related disorders | 1614 (3.8) | 1579 (3.9) | 35 (1.6) |
Number of MH conditionsa | |||
1–2 | 16 631 (39) | 16 021 (39.6) | 610 (28.1) |
3–4 | 19 026 (44.6) | 18 101 (44.7) | 925 (42.6) |
5+ | 6997 (16.4) | 6363 (15.7) | 634 (29.2) |
Number of complex chronic conditiona | |||
0 | 34 121 (80) | 32 965 (81.4) | 1156 (53.3) |
1 | 7075 (16.6) | 6318 (15.6) | 757 (34.9) |
2 | 1187 (2.8) | 990 (2.4) | 197 (9.1) |
3+ | 271 (0.6) | 212 (0.5) | 59 (2.7) |
ICU during hospitalization | 2861 (6.7) | 2725 (6.7) | 136 (6.3) |
Discharge dispositiona | |||
Home | 27 528 (64.5) | 25 914 (64) | 1614 (74.4) |
Other med hosp | 1227 (2.9) | 1081 (2.7) | 146 (6.7) |
Group home/inpt psych | 13 026 (30.5) | 12 655 (31.3) | 371 (17.1) |
Other | 873 (2) | 835 (2.1) | 38 (1.8) |
Hospital resource usea | |||
Median LOS, d [IQR] | 2 [1–5] | 2 [1–4] | 20 [16–30] |
Median hospital cost, $ [IQR] | 6599.5 [3704.8–12 869.1] | 6247.8 [3605.6–11 534] | 45 526.7 [29 176.3–69 531.3] |
Characteristic . | Overall . | <14 D LOS . | 14 + D LOS . |
---|---|---|---|
N discharges | 42 654 | 40 485 (94.9) | 2169 (5.1) |
Age at admissiona | |||
5–10 y | 4375 (10.3) | 4194 (10.4) | 181 (8.3) |
11–13 y | 11 015 (25.8) | 10 462 (25.8) | 553 (25.5) |
14–18 y | 26 629 (62.4) | 25 253 (62.4) | 1376 (63.4) |
19–20 y | 635 (1.5) | 576 (1.4) | 59 (2.7) |
Sexa | |||
Male | 13 405 (31.5) | 12 768 (31.6) | 637 (29.4) |
Female | 29 218 (68.5) | 27 690 (68.4) | 1528 (70.6) |
Race/ethnicitya | |||
Non-Hispanic white | 22 950 (53.8) | 21 795 (53.8) | 1155 (53.3) |
Non-Hispanic Black | 8605 (20.2) | 8170 (20.2) | 435 (20.1) |
Hispanic | 7348 (17.2) | 7004 (17.3) | 344 (15.9) |
Asian | 895 (2.1) | 836 (2.1) | 59 (2.7) |
Otherb | 2856 (6.7) | 2680 (6.6) | 176 (8.1) |
Payera | |||
Government | 20 632 (48.4) | 19 645 (48.5) | 987 (45.5) |
Private | 19 077 (44.7) | 18 012 (44.5) | 1065 (49.1) |
Otherc | 2945 (6.9) | 2828 (7) | 117 (5.4) |
Primary MH conditiona | |||
ADHD | 566 (1.3) | 545 (1.3) | 21 (1) |
Accidental/undetermined poisoning | 979 (2.3) | 966 (2.4) | 13 (0.6) |
Anxiety disorders | 1420 (3.3) | 1405 (3.5) | 15 (0.7) |
Autism spectrum disorder | 1043 (2.4) | 955 (2.4) | 88 (4.1) |
Bipolar and related disorders | 390 (0.9) | 368 (0.9) | 22 (1) |
Depressive disorders | 7079 (16.6) | 6840 (16.9) | 239 (11) |
Developmental delay NOS | 318 (0.7) | 313 (0.8) | 5 (0.2) |
Disruptive, impulse control and conduct disorders | 1622 (3.8) | 1470 (3.6) | 152 (7) |
Feeding/eating disorders | 4660 (10.9) | 3637 (9) | 1023 (47.2) |
Otherd | 2708 (6.3) | 2628 (6.5) | 80 (3.7) |
Schizophrenia spectrum and other psychotic disorders | 972 (2.3) | 848 (2.1) | 124 (5.7) |
Somatic symptom and related disorders | 2134 (5) | 2097 (5.2) | 37 (1.7) |
Substance-related disorders | 1213 (2.8) | 1193 (2.9) | 20 (0.9) |
Suicide or self-injury | 15 936 (37.4) | 15 641 (38.6) | 295 (13.6) |
Trauma and stressor-related disorders | 1614 (3.8) | 1579 (3.9) | 35 (1.6) |
Number of MH conditionsa | |||
1–2 | 16 631 (39) | 16 021 (39.6) | 610 (28.1) |
3–4 | 19 026 (44.6) | 18 101 (44.7) | 925 (42.6) |
5+ | 6997 (16.4) | 6363 (15.7) | 634 (29.2) |
Number of complex chronic conditiona | |||
0 | 34 121 (80) | 32 965 (81.4) | 1156 (53.3) |
1 | 7075 (16.6) | 6318 (15.6) | 757 (34.9) |
2 | 1187 (2.8) | 990 (2.4) | 197 (9.1) |
3+ | 271 (0.6) | 212 (0.5) | 59 (2.7) |
ICU during hospitalization | 2861 (6.7) | 2725 (6.7) | 136 (6.3) |
Discharge dispositiona | |||
Home | 27 528 (64.5) | 25 914 (64) | 1614 (74.4) |
Other med hosp | 1227 (2.9) | 1081 (2.7) | 146 (6.7) |
Group home/inpt psych | 13 026 (30.5) | 12 655 (31.3) | 371 (17.1) |
Other | 873 (2) | 835 (2.1) | 38 (1.8) |
Hospital resource usea | |||
Median LOS, d [IQR] | 2 [1–5] | 2 [1–4] | 20 [16–30] |
Median hospital cost, $ [IQR] | 6599.5 [3704.8–12 869.1] | 6247.8 [3605.6–11 534] | 45 526.7 [29 176.3–69 531.3] |
ADHD, attention-deficit/hyperactivity disorder; inpt psych, inpatient psychiatric hospital specified; IQR, interquartile range; med hosp, medical hospital; NOS, not otherwise specified.
All comparisons were significant at the P < .05 level.
Race and ethnicity other category include: Pacific Islander, Native American, and other unspecified.
Payer other category includes: Self-pay, tricare, no-charge hospitalizations, and other unspecified.
Primary MH condition other category includes: Dissociative disorders, elimination disorders, fetal or newborn damage related to maternal substance use, maternal mental illness or substance abuse during pregnancy, MH symptom, miscellaneous, motor disorders, personality disorders, sexual and gender identity disorders, and sleep–wake disorders.
Patient and Hospitalization Characteristics
Prolonged MH hospitalizations had a slightly higher representation of females (70.6% vs 68.4%, P = .037) and a higher representation of children with private insurance (49.1% vs 44.5%, P < .001) when compared with MH hospitalizations with LOS <14 days. The distribution of primary MH diagnoses differed significantly between prolonged MH hospitalizations versus hospitalizations with LOS ≤14 days. Autism spectrum disorders, eating disorders, and schizophrenia spectrum and other psychotic disorders appeared overrepresented in the prolonged LOS group, whereas anxiety disorders; depressive disorders; disruptive, impulse control, and conduct disorders; suicide or self-injury; and trauma and stressor-related disorders were underrepresented. Prolonged MH hospitalizations had a higher proportion of children with 5 or more MH diagnostic categories (29.2% vs 15.7%, P < .001), and children with any complex chronic conditions (46.7% vs 18.5%, P < .001), and were more frequently discharged to home (74.4% vs 64%, P < .001) compared with MH hospitalizations <14 days. Median hospital costs were 7.3 times higher in prolonged MH hospitalizations compared with MH hospitalizations <14 days ($45 526 vs $6247, P < .001).
Multivariable Analysis
Compared with patients admitted for anxiety disorders, the primary MH diagnosis with the greatest odds of having a prolonged LOS was eating disorders (aOR 24.81; 95% CI 8.11–75.89); schizophrenia or psychotic disorders (aOR 10.63; 95% CI 4.2–26.89); autism spectrum disorder (aOR 7.07; 95% CI 2.7–18.48); and disruptive, impulse control, and conduct disorders (aOR 6.78; 95% CI 2.43–18.92) (Table 2). Prolonged LOS was also associated with children reported as non-Hispanic Black (aOR 1.69; 95% CI 1.2–2.19), other race and ethnicity (1.59 aOR; 95% CI 1.12–2.26), and Asian race (aOR 1.58; 95% CI 1.13–2.2), compared with non-Hispanic white children. Compared with those with 1 or 2 MH diagnoses, the adjusted odds of prolonged LOS increased with 3 to 4 MH diagnoses (aOR 1.6; 95% CI 1.3–1.97) and 5+ MH diagnoses (aOR 3.72; 95% CI 2.89–4.79). Compared with patients with no complex chronic conditions, the odds of prolonged LOS increased with 1 complex chronic condition (aOR 1.58; 95% CI 1.33–1.89), 2 complex chronic conditions (aOR 2.22; 95% CI 1.59–3.11), and 3+ complex chronic conditions (aOR 6.16; 95% CI 3.82–9.93).
. | aOR (95% CI) . |
---|---|
Age at admission | |
5–10 y | Reference |
11–13 y | 1.14 (0.91–1.42) |
14–18 y | 1.05 (0.75–1.47) |
19–20 y | 0.97 (0.62–1.52) |
Sex | |
Male | Reference |
Female | 0.95 (0.84–1.08) |
Race/ethnicity | |
Non-Hispanic white | Reference |
Non-Hispanic Blacka | 1.69 (1.3–2.19) |
Hispanic | 1.26 (0.84–1.9) |
Asiana | 1.58 (1.13–2.2) |
Othera,b | 1.59 (1.12–2.26) |
Payer | |
Government | 1.15 (0.93–1.43) |
Private | Reference |
Otherc | 0.89 (0.51–1.54) |
Primary MH condition | |
ADHDa | 3.18 (1.42–7.13) |
Accidental or undetermined poisoning | 1.37 (0.46–4.08) |
Anxiety disorders | Reference |
Autism spectrum disordera | 7.07 (2.7–18.48) |
Bipolar and related disordersa | 4.26 (2.03–8.97) |
Depressive disorders | 2.89 (1.5–5.56) |
Developmental delay NOS | 1.42 (0.39–5.18) |
Disruptive, impulse control, and conduct disordersa | 6.78 (2.43–18.92) |
Feeding and eating disordersa | 24.81 (8.11–75.89) |
Othera,d | 2.48 (1.19–5.15) |
Schizophrenia spectrum and psychotic disordersa | 10.63 (4.2–26.89) |
Somatic symptom and related disorders | 1.68 (0.66–4.24) |
Substance-related disorders | 1.59 (0.57–4.45) |
Suicide or self-injury | 1.6 (0.69–3.71) |
Trauma and stressor-related disorders | 1.82 (0.96–3.43) |
Number of MH condition | |
1–2 | Reference |
3–4a | 1.6 (1.3–1.97) |
5+a | 3.72 (2.89–4.79) |
Number of complex chronic condition | |
0 | Reference |
1a | 1.58 (1.33–1.89) |
2a | 2.22 (1.59–3.11) |
3+a | 6.16 (3.82–9.93) |
. | aOR (95% CI) . |
---|---|
Age at admission | |
5–10 y | Reference |
11–13 y | 1.14 (0.91–1.42) |
14–18 y | 1.05 (0.75–1.47) |
19–20 y | 0.97 (0.62–1.52) |
Sex | |
Male | Reference |
Female | 0.95 (0.84–1.08) |
Race/ethnicity | |
Non-Hispanic white | Reference |
Non-Hispanic Blacka | 1.69 (1.3–2.19) |
Hispanic | 1.26 (0.84–1.9) |
Asiana | 1.58 (1.13–2.2) |
Othera,b | 1.59 (1.12–2.26) |
Payer | |
Government | 1.15 (0.93–1.43) |
Private | Reference |
Otherc | 0.89 (0.51–1.54) |
Primary MH condition | |
ADHDa | 3.18 (1.42–7.13) |
Accidental or undetermined poisoning | 1.37 (0.46–4.08) |
Anxiety disorders | Reference |
Autism spectrum disordera | 7.07 (2.7–18.48) |
Bipolar and related disordersa | 4.26 (2.03–8.97) |
Depressive disorders | 2.89 (1.5–5.56) |
Developmental delay NOS | 1.42 (0.39–5.18) |
Disruptive, impulse control, and conduct disordersa | 6.78 (2.43–18.92) |
Feeding and eating disordersa | 24.81 (8.11–75.89) |
Othera,d | 2.48 (1.19–5.15) |
Schizophrenia spectrum and psychotic disordersa | 10.63 (4.2–26.89) |
Somatic symptom and related disorders | 1.68 (0.66–4.24) |
Substance-related disorders | 1.59 (0.57–4.45) |
Suicide or self-injury | 1.6 (0.69–3.71) |
Trauma and stressor-related disorders | 1.82 (0.96–3.43) |
Number of MH condition | |
1–2 | Reference |
3–4a | 1.6 (1.3–1.97) |
5+a | 3.72 (2.89–4.79) |
Number of complex chronic condition | |
0 | Reference |
1a | 1.58 (1.33–1.89) |
2a | 2.22 (1.59–3.11) |
3+a | 6.16 (3.82–9.93) |
ADHD, attention-deficit/hyperactivity disorder; NOS, not otherwise specified.
Comparison was significant at the P < .05 level.
Race and ethnicity other category includes: Pacific Islander, Native American, and other unspecified.
Payer other category includes: Self-pay, tricare, no-charge hospitalizations, and other unspecified.
Primary MH condition other category includes: Dissociative disorders, elimination disorders, fetal or newborn damage related to maternal substance use, maternal mental illness or substance abuse during pregnancy, MH symptom, miscellaneous, motor disorders, personality disorders, sexual and gender identity disorders, and sleep–wake disorders.
Variation in Prolonged MH Hospitalizations Across Children’s Hospitals
After controlling for demographic and clinical factors, there was significant (P < .001) interhospital variation in the percentage of all MH hospitalizations that had a prolonged LOS (range 0%–22.4%) (Fig 2). Variation in prolonged LOS across hospitals was not associated with volume of MH hospitalizations at each hospital.
Sensitivity Analysis
Excluding patients admitted for eating disorders moved our main outcome measure (ie, the 95th percentile of LOS) from ≥14 days to ≥10 days. However, our results remained otherwise relatively unchanged. Although some point estimates and CI changed (Supplemental Table 4) no variables (medical complexity, MH complexity, MH diagnoses categories) lost or gained statistical significance (Supplemental Table 5). Additionally, the rank order of strength of association of MH diagnoses remained unchanged (ie, aORs were greatest for autism spectrum disorder followed by bipolar and related disorders and so forth). The lone exception was race and ethnicity, where non-Hispanic Black children were the only group that remained with a higher odd of prolonged LOS (aOR 1.54; 95% CI 1.25–1.9; P < .001), and categorization of Asian race or other race was no longer associated with prolonged LOS.
Discussion
In this retrospective analysis of children aged 5 to 20 years primarily hospitalized for an MH condition at children’s hospitals, we identified numerous categories of MH diagnoses associated with a prolonged LOS. These findings were robust and unchanged in our sensitivity analysis excluding children hospitalized with a primary diagnosis for a feeding and eating disorder. Children’s number of comorbid MH diagnoses and medical complexity were also associated with prolonged LOS. Collectively, these results can inform in-hospital systems of care and community resources need to minimize prolonged MH hospitalizations at acute care children’s hospitals.
We identified numerous categories of MH diagnoses strongly associated with prolonged LOS that require unique systems of care. Eating disorders; autism spectrum disorder; schizophrenia and psychotic disorders; and disruptive, impulse control, and conduct disorders were all strongly associated with prolonged MH hospitalizations. Eating disorder was the most prevalent and most highly associated condition associated with prolonged MH hospitalizations, which is consistent with recent studies.14 This result highlights the continued need to increase care capacity for children suffering from eating disorders.15,16 The association between eating disorders and prolonged MH hospitalization may be influenced by a lack of clear guidelines for the management of malnutrition and hospital discharge criteria for children with eating disorders,17 and further studies exploring variation in care of eating disorder management and associations with LOS are needed.
Autism spectrum disorder; schizophrenia and psychotic disorders; and disruptive, impulse control, and conduct disorders were also strongly associated with prolonged MH hospitalizations. Children hospitalized primarily for these conditions engage in high levels of challenging behavior (eg, physical aggression, property destruction, and self-injury),18,19 and such behavior can escalate, influencing discharge disposition and prolong the hospitalization.8,20–22 Providers such as psychologists and psychiatrists are imperative in the implementation of behavioral and pharmacologic interventions to reduce a child’s overall acuity.23–25 Behavior analysts are other key providers who identify the underlying cause of behavior and create interventions to (1) avoid and manage behavioral escalations and (2) promote appropriate behavior. Targeted services and behavior plans are associated with reduction in pharmacologic and physical restraints, and improved provider satisfaction, and may decrease hospital LOS.23,26–28 Decreasing a child’s MH acuity can improve patient and hospital staff outcomes,25–27 and may impact LOS by:
Notably, patients with prolonged LOS were most likely to be discharge to home, which may relate to this reverse triaging phenomenon and lack of inpatient resources versus medical limitations in discharge to home earlier. Despite optimization of inpatient MH supports safe discharge plans frequently require community-based MH resources, which unfortunately are in a critical shortage.8 Further studies examining the associations between MH hospitalization LOS with inpatient and community MH resources are needed.
Compared with non-Hispanic white children, we observed that non-Hispanic Black, Asian, and children of other race and ethnicity each had higher odds of prolonged hospitalization, congruent with other pediatric literature describing race- and ethnicity-associated differences in hospital LOS.30 Our study was not designed to assess reasons for this difference, and the influence of factors prehospitalization (eg, differences in access to care, differences in exposure to childhood trauma which may result in more severe MH disease among different racial or ethnic constructs) and/or factors during hospitalization are unclear. Time to diagnosis and treatment in the outpatient treatment of MH conditions are associated with patient race,31–33 and perhaps race-associated differences in the care of children hospitalized with MH conditions are influencing hospital LOS. Additionally, unconscious bias exists in the evaluation and treatment plans of patients evaluated by psychiatrists, and unconscious bias may have contributed to our findings.34 There may be real or perceived race-associated barriers in posthospitalization care, which could impact hospital LOS. Our study highlights the need for special attention to sociodemographic risk factors when caring for children hospitalized with MH hospitalizations, and the need to consider equity and family-centered care when discharge planning.35
We found significant stepwise associations between prolonged MH hospitalizations and number of complex chronic conditions, suggesting that, not only do MH comorbidities prolong medical admissions,36 medical complexity also prolongs MH hospitalizations. Medical complexity likely complicates behavioral and/or psychiatric care and may represent a barrier to safe discharge. Our results highlight the need for continued investigations into the role of pediatric med–psych units (ie, units within medical hospitals dedicated to care for patients with both physical and MH needs). Studies of adult med–psych units suggest that they may be associated with shorter LOS and decreased 30-day readmission.37 Although pediatric med–psych units are becoming more prevalent to match the need for complex pediatric medical and MH care, further data of such units, including cost variance analysis, as well as studies testing the associations of pediatric med–psych units and patient and staff outcomes, are needed.
We found substantial variation in the prevalence of prolonged MH hospitalizations across US children’s hospitals, which persisted after adjusting for factors associated with prolonged MH hospitalizations (eg, volume and types of MH conditions seen at each hospital). Hospital-level variation in the prevalence of MH hospitalizations with a prolonged LOS may indicate differences in discharge criteria or regional options for ongoing postdischarge MH care, be it outpatient or inpatient. Variation may also represent opportunities to decrease LOS through strategic planning of community resources, enhanced MH support in the inpatient setting, and evidence-based care for coexisting medical needs. Understanding systems and resources available at those hospitals with the lowest prevalence of prolonged MH hospitalizations may reveal best practices which can be disseminated across pediatric medical centers.
This study’s findings should be considered in the context of several limitations. Most PHIS-reporting hospitals are academic tertiary or quaternary care hospitals, and our study findings may not generalize to community hospitals where most children are hospitalized. Second, the identification of MH conditions relies on proper documentation and coding practices, which can vary across hospitals. Third, we acknowledge there may be factors that are associated with prolonged MH hospitalizations that were unable to be measured by our study design. For example, severity of challenging behaviors, guardianship barriers, and availability and types of community-based services may be associated with prolonged LOS but were unable to be elucidated utilizing administrative data. Finally, the time frame of our study was after the start of the coronavirus disease 2019 (COVID-19) pandemic. Closure of residential or psychiatric facilities related to COVID-19, and policies related to testing for and/or isolation of children because of COVID-19, may have influenced hospital LOS. It is uncertain if these policies affected children with certain clinical or sociodemographic characteristics more than others, and/or to what degree a comorbid COVID-19 diagnosis affected LOS.
Conclusions
We identified characteristics of patients at US children’s hospitals where expanded investments in community- and hospital-level MH services, such as behavioral therapy and specialized behavioral units, have the potential to improve health outcomes, equity, and reduce LOS and cost of MH hospitalizations.
Dr DePorre conceptualized and designed the study, drafted the initial manuscript, interpreted the data, and reviewed and revised the manuscript; Dr Hall conducted the statistical analyses, supervised data interpretation, and reviewed and revised the manuscript; Drs Nadler and Bernstein assisted with study design and initial manuscript writing, and critically reviewed the manuscript for intellectual content; Dr Puls supervised and assisted with study design, critical interpretation of data, and manuscript preparation and revision; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
FUNDING: No external funding.
CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.
Comments